Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CHEK-ATP126 | Human | HEK293/Human B7-H4 Stable Cell Line | |||
B74-M52H7 | Mouse | Azide-labeled Mouse B7-H4 Protein, His Tag (MALS verified) |
|
||
B74-C52H8 | Canine | Canine B7-H4 Protein, His Tag (MALS verified) |
|
|
|
B74-R52H9 | Rat | Rat B7-H4 Protein, His Tag |
|
|
|
B74-C52H9 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque B7-H4 Protein, His Tag (MALS verified) |
|
|
|
B74-M52H9 | Mouse | Mouse B7-H4 Protein, His Tag |
|
||
B74-H5256 | Human | Human B7-H4 Protein, Fc Tag, low endotoxin |
|
|
|
B74-H82E2 | Human | Biotinylated Human B7-H4 Protein, Avitag™,His Tag (recommended for biopanning) |
|
|
|
B74-H8222 | Human | Biotinylated Human B7-H4 Protein, His Tag, ultra sensitivity (primary amine labeling) |
|
|
|
B74-H5222 | Human | Human B7-H4 Protein, His Tag (MALS verified) |
|
|
Expression analysis of human B7-H4 on HEK293/Human B7-H4 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human B7-H4 Stable Cell Line or negative control cell using PE-labeled anti-human B7-H4 antibody.
Anti-B7-H4 antibody, Human IgG1 captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Canine B7-H4, His Tag (Cat. No. B74-C52H8) with an affinity constant of 8.59 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
AZD-8205 | AZD-8205 | Phase 2 Clinical | Astrazeneca Plc | Ovarian Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Endometrial Neoplasms | Details |
HS-20089 | HS-20089 | Phase 1 Clinical | Shanghai Hansoh Biomedical Co Ltd | Solid tumours | Details |
XMT-1660 | XMT-1660 | Phase 1 Clinical | Mersana Therapeutics Inc | Ovarian Neoplasms; Abdominal Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Breast Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms | Details |
NC-762 | NC-762 | Phase 2 Clinical | Nextcure Inc | Ovarian Neoplasms; Solid tumours; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
HBM-7008 | HBM7008; HBM-7008; R-7008 | Phase 1 Clinical | Harbour Biomed | Solid tumours | Details |
Alsevalimab | FPA-150 | Phase 1 Clinical | Five Prime Therapeutics Inc | Solid tumours; Ovarian Neoplasms; Neoplasms; Breast Neoplasms; Endometrial Neoplasms | Details |
SGN-B7H4V | SGN-B-7H-4V; SGNB-7H4V; SGNB-7H-4V; SGN-B7H4V | Phase 1 Clinical | Seagen Inc | Ovarian Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Adenoid Cystic; Cholangiocarcinoma; Breast Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Gallbladder Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
GEN-1047 | GEN-1047 | Phase 2 Clinical | Genmab A/S | Ovarian Neoplasms; Breast Neoplasms; Uterine Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
PF-07260437(Pfizer) | PF-07260437 | Phase 1 Clinical | Pfizer Inc | Ovarian Neoplasms; Breast Neoplasms; Endometrial Neoplasms | Details |
This web search service is supported by Google Inc.